首页 > 最新文献

The Brown University Psychopharmacology Update最新文献

英文 中文
Use of SSRIs with anticoagulants can increase risk of bleeding 使用 SSRIs 和抗凝血剂会增加出血风险
Pub Date : 2024-09-04 DOI: 10.1002/pu.31218
{"title":"Use of SSRIs with anticoagulants can increase risk of bleeding","authors":"","doi":"10.1002/pu.31218","DOIUrl":"https://doi.org/10.1002/pu.31218","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Approval 批准
Pub Date : 2024-09-04 DOI: 10.1002/pu.31221
{"title":"Approval","authors":"","doi":"10.1002/pu.31221","DOIUrl":"https://doi.org/10.1002/pu.31221","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-psychotic use in dementia patients linked to risk of numerous illnesses 痴呆症患者服用抗精神病药与多种疾病风险有关
Pub Date : 2024-09-04 DOI: 10.1002/pu.31219
{"title":"Anti-psychotic use in dementia patients linked to risk of numerous illnesses","authors":"","doi":"10.1002/pu.31219","DOIUrl":"https://doi.org/10.1002/pu.31219","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142137775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
Pub Date : 2024-08-02 DOI: 10.1002/pu.31209

Aripiprazole (generic) — Abilify (brand)

阿立哌唑(非专利药) - Abilify(品牌药)
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31209","DOIUrl":"https://doi.org/10.1002/pu.31209","url":null,"abstract":"<p>Aripiprazole (generic) — Abilify (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lipid-modifying statins, fibrates reduce mortality in schizophrenia patients 调节血脂的他汀类药物和纤维酸盐可降低精神分裂症患者的死亡率
Pub Date : 2024-08-02 DOI: 10.1002/pu.31199

A nationwide cohort study conducted in Taiwan has found that lipid-modifying agents, particularly statins and fibrates, reduce mortality risk in patients with schizophrenia. The reduced risk was apparent for both all-cause and natural-cause mortality, the investigators reported. Study results were published online May 16, 2024, in The British Journal of Psychiatry.

台湾进行的一项全国性队列研究发现,血脂调节剂,尤其是他汀类药物和纤维酸盐,可降低精神分裂症患者的死亡风险。研究人员报告说,降低的风险在全因死亡率和自然死亡率中都很明显。研究结果于2024年5月16日在线发表在《英国精神病学杂志》上。
{"title":"Lipid-modifying statins, fibrates reduce mortality in schizophrenia patients","authors":"","doi":"10.1002/pu.31199","DOIUrl":"https://doi.org/10.1002/pu.31199","url":null,"abstract":"<p>A nationwide cohort study conducted in Taiwan has found that lipid-modifying agents, particularly statins and fibrates, reduce mortality risk in patients with schizophrenia. The reduced risk was apparent for both all-cause and natural-cause mortality, the investigators reported. Study results were published online May 16, 2024, in <i>The British Journal of Psychiatry</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dutasteride reduced alcohol use among heavy-drinking men 度他雄胺减少了酗酒男性的饮酒量
Pub Date : 2024-08-02 DOI: 10.1002/pu.31208
{"title":"Dutasteride reduced alcohol use among heavy-drinking men","authors":"","doi":"10.1002/pu.31208","DOIUrl":"https://doi.org/10.1002/pu.31208","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Many women not heeding warnings on valproic acid's risks in pregnancy 许多妇女没有注意到关于丙戊酸在怀孕期间的风险警告
Pub Date : 2024-08-02 DOI: 10.1002/pu.31198

Despite intensified warnings from regulators about fetal risk associated with the use of valproic acid during pregnancy, pregnancy incidence rates in women receiving valproic acid have remained largely unchanged, results of a cohort study suggest. Use of contraception in this population has also remained low overall, the investigators reported. Study results were published May 22, 2024, in JAMA Network Open.

一项队列研究结果表明,尽管监管机构加强了对妊娠期使用丙戊酸对胎儿风险的警告,但接受丙戊酸治疗的妇女的妊娠发生率基本保持不变。研究人员报告说,这一人群使用避孕药具的比例总体上也很低。研究结果于 2024 年 5 月 22 日发表在《美国医学会杂志网络版》(JAMA Network Open)上。
{"title":"Many women not heeding warnings on valproic acid's risks in pregnancy","authors":"","doi":"10.1002/pu.31198","DOIUrl":"https://doi.org/10.1002/pu.31198","url":null,"abstract":"<p>Despite intensified warnings from regulators about fetal risk associated with the use of valproic acid during pregnancy, pregnancy incidence rates in women receiving valproic acid have remained largely unchanged, results of a cohort study suggest. Use of contraception in this population has also remained low overall, the investigators reported. Study results were published May 22, 2024, in <i>JAMA Network Open</i>.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence fails to support use of pharmacogenomic tools in depression treatment 在抑郁症治疗中使用药物基因组工具的证据不足
Pub Date : 2024-08-02 DOI: 10.1002/pu.31204
{"title":"Evidence fails to support use of pharmacogenomic tools in depression treatment","authors":"","doi":"10.1002/pu.31204","DOIUrl":"https://doi.org/10.1002/pu.31204","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Varenicline effective after treatment failure for smoking cessation 伐伦克林对戒烟治疗失败后有效
Pub Date : 2024-08-02 DOI: 10.1002/pu.31202

Groups of patients who did not achieve abstinence from smoking after initial treatment with varenicline or nicotine replacement therapy saw improved results with subsequent strategies involving varenicline, a randomized trial has found. Nonabstainers who had received varenicline in the initial treatment phase benefited from a dosage increase in the follow-up phase.

一项随机试验发现,在使用伐伦克林或尼古丁替代疗法进行初始治疗后未能戒烟的患者群体,在使用伐伦克林的后续策略后效果有所改善。在初始治疗阶段接受过伐伦克林治疗的未戒烟者在后续治疗阶段因剂量增加而受益。
{"title":"Varenicline effective after treatment failure for smoking cessation","authors":"","doi":"10.1002/pu.31202","DOIUrl":"https://doi.org/10.1002/pu.31202","url":null,"abstract":"<p>Groups of patients who did not achieve abstinence from smoking after initial treatment with varenicline or nicotine replacement therapy saw improved results with subsequent strategies involving varenicline, a randomized trial has found. Nonabstainers who had received varenicline in the initial treatment phase benefited from a dosage increase in the follow-up phase.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drug interactions and pain control 药物相互作用与疼痛控制
Pub Date : 2024-08-02 DOI: 10.1002/pu.31200
Y. W. Francis Lam Pharm.D., FCCP

Opioid analgesics such as codeine, hydrocodone, and tramadol undergo metabolism that is mediated by the polymorphic CYP2D6 isoenzyme, and research has shown that a CYP2D6 genotype-guided approach to pain control can optimize effectiveness and/or minimize adverse drug reactions associated with these analgesics in patients with different CYP2D6 genotypes (Smith et al., 2019).

可待因、氢可酮和曲马多等阿片类镇痛药的代谢是由多态 CYP2D6 同工酶介导的,研究表明,CYP2D6 基因型指导下的疼痛控制方法可以优化不同 CYP2D6 基因型患者使用这些镇痛药的效果和/或最大限度地减少与之相关的药物不良反应(Smith 等人,2019 年)。
{"title":"Drug interactions and pain control","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31200","DOIUrl":"https://doi.org/10.1002/pu.31200","url":null,"abstract":"<p>Opioid analgesics such as codeine, hydrocodone, and tramadol undergo metabolism that is mediated by the polymorphic CYP2D6 isoenzyme, and research has shown that a CYP2D6 genotype-guided approach to pain control can optimize effectiveness and/or minimize adverse drug reactions associated with these analgesics in patients with different CYP2D6 genotypes (Smith et al., 2019).</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141966757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Brown University Psychopharmacology Update
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1